antimuscarinic agents

antimuscarinic agents

; anticholinergic agents agents that reduce symptoms of parkinsonism
Mentioned in ?
References in periodicals archive ?
Also, recent large observational studies provide some evidence that concomitant long-term use of inhaled antimuscarinic agents or beta agonists along with cardioselective beta blockers actually reduces mortality rates and the risk of exacerbations in patients with COPD (54,55).
A has mild dementia managed by donepezil; limited evidence suggests that antimuscarinic agents should be used with caution in patients with impaired cognition, especially when used in combination with other drugs with potential anticholinergic effects (Orme, Morris, Gibson, & Wagg, 2015).
13,14) Antimuscarinic agents represent a common drug treatment option for OAB that has been used for over 30 years.
Antimuscarinic agents dilate the pupil (mydriasis) and paralyse the ciliary muscle (cycloplegia), relieving pain for the patient.
23) Several antimuscarinic agents are now available which vary in their muscarinic receptor affinity, formulation, and dose flexibility (TABLE 1).
Additionally, some patients that experience bothersome side effects of antimuscarinic agents may realize sufficient benefit and improved tolerability from a dosage reduction.
Antimuscarinic agents, used to treat overactive bladder, including oxybutinin (Ditropan) and benzhexol hydrochloride (Benzhexol)
Antimuscarinic agents as substances of abuse: A review.
Medications called antimuscarinic agents that relax the detrusor muscle and prevent abnormal contractions are commonly prescribed for OAB.
The greatest efficacy in treating OAB is achieved using combination therapy with behavioral modification and pharmacologic treatment with antimuscarinic agents.